CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Johnson & Johnson (OLD) is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Johnson & Johnson (OLD)
One Johnson & Johnson Plaza
Phone: (732) 524-0400p:732 524-0400 New Brunswick, NJ  08933  United States Ticker: JNJ JNJ
This company was Merged or Acquired on 6/22/2001.
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company
Business Summary
Johnson & Johnson manufactures and sells of a broad range of products in the health care field. It conducts business in virtually all countries. The Company's primary interest, both historically and currently, has been in products related to human health and well being. Johnson & Johnson's worldwide business is divided into three segments: Consumer, Pharmaceutical and Professional. The Consumer segment's principal products are personal care and hygienic products, including nonprescription drugs, adult skin and hair care products, baby care products, oral care products, first aid products and sanitary protection products. The Pharmaceutical segment's principal worldwide franchises are in the antifungal, anti-infective, cardiovascular, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, psychotropic and women's health fields. The Professional segment includes a broad range of products used by or under the direction of health care professionals.
(Source: 10-K405)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
----YesYes-

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
--Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2676 Sanitary paper products
3842 Orthopedic, prosthetic, and surgical appliances and supplies
2844 Perfumes, cosmetics, and other toilet preparations
2833 Medicinal chemicals and botanical products
2843 Surface active agents, finishing agents, sulfonated oils
2835 In vitro and in vivo diagnostic substances
2836 Biological products, except diagnostic substances
3851 Ophthalmic goods
3841 Surgical and medical instruments and apparatus

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board and Chief Executive Officer Ralph S.Larsen 66 1/1/1993
Vice Chairman of the Board Medical Devices & Diagnostics Group James T.Lenehan 55 2/13/2001 1/1/1993
Vice Chairman of the Board William C.Weldon 52 2/13/2001 6/1/1998
9 additional Officers and Directors records available in full report.

General Information
Number of Employees: 98,500 (As of 12/31/2000)
Outstanding Shares: 2,793,942,120 (As of 6/13/2001)
Shareholders: 164,158
Stock Exchange: NYSE
Federal Tax Id: 221024240
Fax Number: (732) 214-0332


Copyright © 2022 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, May 26, 2022